Engineering the future of blood health through advanced transfusion medicine, vascular biology research, and novel cellular therapies. Discover our RNA and stem cell innovations.

Clotting and bleeding disorders affect millions, from stroke and heart attack to hemophilia and von Willebrand disease. VBRI’s Thrombosis & Hemostasis program studies how clots form, why they form in the wrong places, and why some patients bleed. We translate molecular insights into better diagnostics and new treatment options.

Every blood cell starts as a stem cell, and every immune response depends on precise cellular decisions. VBRI’s Hematopoiesis & Immunology program studies how blood and immune cells develop, and what happens when those processes break down. This molecular research helps advance new approaches for blood cancers, autoimmune disease, and immune disorders.

Translational research turns what we learn in the lab into better care. VBRI’s Translational Hematology program brings clinician-scientists together to study blood disorders based on real patient needs. From epidemiology and diagnostics to clinical trials like VENUS and national transfusion work through REDS-IV-P, we advance safer, more effective treatment.